Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers

Neuropathic pain affects ~ 6.9–10% of the general population and leads to loss of function, anxiety, depression, sleep disturbance, and impaired cognition. Here, we report the safety, tolerability, and pharmacokinetics of a voltage‐dependent and use‐dependent sodium channel blocker, vixotrigine, cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, Himanshu, Steiner, Deb J., Versavel, Mark, Palmer, Joanne, Fong, Regan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301589/
https://www.ncbi.nlm.nih.gov/pubmed/33278330
http://dx.doi.org/10.1111/cts.12935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301589/
https://www.ncbi.nlm.nih.gov/pubmed/33278330
http://dx.doi.org/10.1111/cts.12935

Ejemplares similares